Carregant...
Acute flare of Bullous Pemphigus with Pembrolizumab used for treatment of metastatic urothelial cancer.
In the past decade, the resurgence of immunotherapy has changed the landscape of cancer therapy. Check point inhibitors targeting CTLA4 (Cytotoxic T-lymphocyte antigen-4), PD-1 (programmed death1) on lymphocytes and PD-L1 (programmed death ligand1) on tumors cells are currently utilized in the manag...
Guardat en:
| Publicat a: | J Immunother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6339565/ https://ncbi.nlm.nih.gov/pubmed/29111983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000191 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|